Molecular shape diversity of combinatorial libraries: A prerequisite for broad bioactivity

Journal of Chemical Information and Computer Sciences

Volumn 43, Issue 3, 2003, Pages 987-1003

  Sauer, Wolfgang H B ^a   Schwarz, Matthias K ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINATORIAL LIBRARIES;

BIODIVERSITY; COMBINATORIAL MATHEMATICS; MOLECULAR STRUCTURE; REDUNDANCY;

DIGITAL LIBRARIES;

DRUG;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; CONFORMATION; METHODOLOGY; STRUCTURE ACTIVITY RELATION;

COMBINATORIAL CHEMISTRY TECHNIQUES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PHARMACEUTICAL PREPARATIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0038512037     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci025599w     Document Type: Article

References (88)

1. Balkenhohl, F.; von dem Bussche-Huennefeld, C.; Lansky, A.; Zechel, C. Combinatorial Synthesis of Small Organic Molecules. Angew.Chem., Int. Ed. Engl. 1996, 35, 2288-2337.
2. Thompson, L. A.; Ellman J. A. Synthesis and Applications of Small Molecule Libraries. Chem. Rev. 1996, 555-600.
3. Gordon, E. M.; Gallop, M. A.; Patel, D. V. Strategy and Tactics in Combinatorial Organic Synthesis. Applications to Drug Discovery. Acc. Chem. Res. 1996, 29, 144-154.
4. Katritzky, A. R.; Kiely, J. S.; Hebert, N.; Chassaing, C. Definition of Templates within Combinatorial Libraries. J. Comb. Chem. 2000, 2, 2-5.
5. Weber, L. High-diversity combinatorial libraries. Curr. Opin. Chem. Biol. 2000, 4, 295-302.
6. Maggiora, G. M.; Shanmugasundaram, V. On the similarity of chemistry spaces. Abstr. Pap. - Am. Chem. Soc. 2001, 221st, COMP-077.
7. Patterson, D. E.; Cramer, R. D.; Ferguson, A. M.; Clark, R. D.; Weinberger, L. E. Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. J. Med. Chem. 1996, 39, 3049-3059.
8. Katritzky, A. R.; Gordeeva, E. V. Traditional topological indexes vs electronic, geometrical, and combined molecular descriptors in QSAR/QSPR research. J. Chem. Inf. Comput. Sci. 1993, 33, 835-857.
9. Matter, H. Selecting Optimally Diverse Compounds from Structure Databases: A Validation Study of Two-Dimensional and Three-Dimensional Molecular Descriptors. J. Med. Chem. 1997, 40, 1219-1229.
10. Matter, H. A validation study of molecular descriptors for the rational design of peptide libraries. J. Pept. Res. 1998, 52, 305-314.
11. Palm, K.; Luthman, K.; Ungell, A. L.; Strandlund, G.; Beigi, F.; Lundahl, P.; Artursson, P. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. J. Med. Chem. 1998, 41, 5382-5392.
12. Bursi, R.; Dao, T.; van Wijk, T.; de Gooyer, M.; Kellenbach, E.; Verwer, P. Comparative spectra analysis (CoSA): spectra as three-dimensional molecular descriptors for the prediction of biological activities. J. Chem. Inf. Comput. Sci. 1999, 39, 861-867.
13. Xue, L.; Godden, J.; Gao, H.; Bajorath, J. Identification of a preferred set of molecular descriptors for compound classification based on principal component analysis. J. Chem. Inf. Comput. Sci. 1999, 39, 699-704.
14. Xue, L.; Bajorath, J. Molecular descriptors for effective classification of biologically active compounds based on principal component analysis identified by a genetic algorithm. J. Chem. Inf. Comput. Sci. 2000, 40, 801-809.
15. Xue, L.; Godden, J. W.; Bajorath, J. Evaluation of descriptors and mini-fingerprints for the identification of molecules with similar activity. J. Chem. Inf. Comput. Sci. 2000, 40, 1227-1234.
16. Labute, P. A widely applicable set of descriptors. J. Mol. Graphics Modell. 2000, 18, 464-477.
17. Brown, R. D.; Martin, Y. C. Use of Structure-Activity Data to Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection. J. Chem. Inf. Comput. Sci. 1996, 36, 572-584.
18. Brown, R. D.; Martin, Y. C. The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding. J. Chem. Inf. Comput. Sci. 1997, 37, 1-9.
19. Martin, Y. C.; Bures, M. G.; Brown, R. D. Validated descriptors for diversity measurements and optimization. Pharm. Pharmacol. Commun. 1998, 4, 147-152.
20. Basak, S. C.; Harriss, D. K.; Magnuson, V. R. Comparative study of lipophilicity versus topological molecular descriptors in biological correlations. J. Pharm. Sci. 1984, 73, 429-437.
21. Randic, M. Orthogonal molecular descriptors. New J. Chem. 1991, 15, 517-525.
22. Randic, M. Generalized molecular descriptors. J. Math. Chem. 1991, 7, 155-168.
23. Willett, P.; Barnard, J. M.; Downs, G. M. Chemical similarity searching. J. Chem. Inf. Comput. Sci. 1998, 38, 983-996.
24. Bayada, D. M.; Hamersma, H.; van Geerestein, V. J. Molecular diversity and representativity in chemical databases. J. Chem. Inf. Comput. Sci. 1999, 39, 1-10.
25. Pearlman, R. S.; Smith, K. M. Metric Validation and the Receptor-Relevant Subspace Concept. J. Chem. Inf. Comput. Sci. 1999, 39, 28-35.
26. Stanton, D. T. Evaluation and Use of BCUT Descriptors in QSAR and QSPR Studies. J. Chem. Inf. Comput. Sci. 1999, 39, 11-20.
27. Martin, E. J.; Blaney, J. M.; Siani, M. A.; Spellmeyer, D. C.; Wong, A. K.; Moos, W. H. Measuring Diversity: Experimental Design of Combinatorial Libraries for Drug Discovery. J. Med. Chem. 1995, 38, 1431-1436.
28. Pickett, S. D.; Luttmann, C.; Guerin, V.; Laoui, A.; James, E. DIVSEL and COMPLIB - strategies for the design and comparison of combinatorial libraries using pharmacophoric descriptors. J. Chem. Inf. Comput. Sci. 1998, 38, 144-150.
29. Xue, L.; Bajorath, J. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Comb. Chem. High Throughput Screen. 2000, 3, 363-372.
30. Bemis, G. W.; Murcko, M. A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996, 39, 2887-2893.
31. Walters, W. P.; Ajay; Murcko, M. A. Recognizing molecules with drug-like properties. Curr. Opin. Chem. Biol. 1999, 3, 384-387.
32. Meyer, A. Y. The Size of Molecules. Chem. Soc. Rev. 1986, 15, 449-474.
33. Kier, L. B.; Hall, L. H. The Molecular Connectivity Chi Indexes and Kappa Shape Indexes in Structure-Property Modeling. In Reviews in Computational Chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH Publishers: New York, U.S.A., 1991; Vol. 2, pp 367-422.
34. Stanton, D. T.; Jurs, P. C. Development and Use of Charged Partial Surface Area Structural Descriptors in Computer-Assisted Quantitative Structure-Property Relationship Studies. Anal. Chem. 1990, 62, 2323-2329.
35. Stouch, T. R.; Jurs, P. C. A Simple Method for the Representation, Quantification, and Comparison of the Volumes and Shapes of Chemical Compounds. J. Chem. Inf. Comput. Sci. 1986, 26, 4-12.
36. catShape4.5, part of the Catalyst package; Accelrys Inc.: San Diego, CA, 2001.
37. Broto, P.; Moreau, G.; Vandycke, C. Molecular structures: perception, autocorrelation descriptor and SAR studies. Eur. J. Med. Chem. - Chim. Ther. 1984, 19, 61-65, 66-70, 71-78, 79-84.
38. Todeschini, R.; Consonni, V. Handbook of Molecular Descriptors; Wiley-VCH: Weinheim, 2000; pp 352, 390-395.
39. E.g., Cramer, R. D.; Poss, M. A.; Hermsmeier, M. A.; Caulfield, T. J.; Kowala, M. C.; Valentine, M. T. Prospective Identification of Biologically Active Structures By Topomer Shape Similarity Searching. J. Med. Chem. 1999, 42, 3919-3933. Good, A. C.; Richards, W. G. Rapid Evaluation of Shape Similarity Using Gaussian Functions. J. Chem. Inf. Comput. Sci. 1993, 33, 112-116. Meyer, A. Y.; Richards, W. G. Similarity of molecular shape. J. Comput.-Aided Mol. Design 1991, 5, 426-439.
40. E.g., Cramer, R. D.; Poss, M. A.; Hermsmeier, M. A.; Caulfield, T. J.; Kowala, M. C.; Valentine, M. T. Prospective Identification of Biologically Active Structures By Topomer Shape Similarity Searching. J. Med. Chem. 1999, 42, 3919-3933. Good, A. C.; Richards, W. G. Rapid Evaluation of Shape Similarity Using Gaussian Functions. J. Chem. Inf. Comput. Sci. 1993, 33, 112-116. Meyer, A. Y.; Richards, W. G. Similarity of molecular shape. J. Comput.-Aided Mol. Design 1991, 5, 426-439.
41. E.g., Cramer, R. D.; Poss, M. A.; Hermsmeier, M. A.; Caulfield, T. J.; Kowala, M. C.; Valentine, M. T. Prospective Identification of Biologically Active Structures By Topomer Shape Similarity Searching. J. Med. Chem. 1999, 42, 3919-3933. Good, A. C.; Richards, W. G. Rapid Evaluation of Shape Similarity Using Gaussian Functions. J. Chem. Inf. Comput. Sci. 1993, 33, 112-116. Meyer, A. Y.; Richards, W. G. Similarity of molecular shape. J. Comput.-Aided Mol. Design 1991, 5, 426-439.
42. 3CFO. Spectrochim. Acta 1965, 21, 119-125.
43. 3CFO. Spectrochim. Acta 1965, 21, 119-125.
44. 3CFO. Spectrochim. Acta 1965, 21, 119-125.
45. 3CFO. Spectrochim. Acta 1965, 21, 119-125.
46. 3CFO. Spectrochim. Acta 1965, 21, 119-125.
47. 3CFO. Spectrochim. Acta 1965, 21, 119-125.
48. 3CFO. Spectrochim. Acta 1965, 21, 119-125.
49. 3CFO. Spectrochim. Acta 1965, 21, 119-125.
50. 2 Modelling Environment; Accelrys Inc.: San Diego, CA.
51. Molecular Operating Environment; Chemical Computing Group: Montreal, Canada.
52. Sybyl. Tripos Inc.: St. Louis, MO.
53. Tsar (Tools for Structure Activity Relationships). Accelrys Inc.: San Diego, CA.
54. Gasteiger, J.; Rudolph, C.; Sadowski, J. Automatic generation of 3D atomic coordinates for organic molecules. Tetrahedron Comput. Methodol. 1990, 3, 537-547.
55. Sadowski, J.; Rudolph, C.; Gasteiger, J. The generation of 3D models of host-guest complexes. Anal. Chim. Acta 1992, 265, 233-241.
56. Dolle, R. E. Comprehensive survey of combinatorial libraries with undisclosed biological activity: 1992-1997. Mol. Diversity 1998, 4, 233-256.
57. Dolle, R. E.; Nelson, K. H., Jr. Comprehensive survey of combinatorial library synthesis: 1998. J. Comb. Chem. 1999, 1, 235-282.
58. Dolle, R. E. Comprehensive survey of combinatorial library synthesis: 1999. J. Comb. Chem. 2000, 2, 383-433.
59. Dolle, R. E. Comprehensive survey of combinatorial library synthesis: 2000. J. Comb. Chem. 2001, 3, 477-517.
60. Carbo, R.; Leyda, L.; Arnau, M. An electron density measure of the similarity between two compounds. Int. J. Quantum Chem. 1980, 17, 1185-1189.
61. Hodgkin, E. E.; Richards, W. G. Molecular similarity based on electrostatic potential and electric field. Int. J. Quantum Chem. Quantum Biol. Symp. 1987, 14, 105-110.
62. Asp 3.23 Reference Guide; Oxford Molecular: Oxford, UK, 2000; pp 2-2-2-3.
63. Note that "fraction of compounds" will only give values different from those obtained from "number of compounds", if the Hodgkin formula is employed and the two libraries differ in their respective total numbers of compounds.
64. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-748. The data set is available online at http://www.ccdc.cam.ac.uk/prods/gold/value.html.
65. Allen, F. H.; Bellard, S.; Brice, M. D.; Cartwright, B. A.; Doubleday: A.; Higgs, H.; Hummelink, T.; Hummelink-Peters, B. G.; Kennard, O.; Motherwell, W. D. S.; S.Rodgers, J. R.; Watson D. G. The Cambridge Crystallographic Data Centre: computer-based search, retrieval, analysis and display of information. Acta Crystallogr. 1979, B35, 2331-2339.
66. Sadowski, J.; Gasteiger, J.; Klebe, G. Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures. J. Chem. Inf. Comput. Sci. 1994, 34, 1000-1008.
67. Sadowski, J.; Gasteiger, J. From atoms and bonds to three-dimensional atomic coordinates: automatic model builders. Chem. Rev. 1993, 93, 2567-2581.
68. E.g., Nicklaus, M. C.; Wang, S.; Driscoll, J. S.; Milne, G. W. A. Conformational Changes Of Small Molecules Binding To Proteins. Bioorg. Med. Chem. 1995, 3, 411-428.
69. catConf 4.5, part of the Catalyst package; Accelrys Inc.: San Diego CA, 2001.
70. Gasteiger, J.; Kleinoder, T.; Sadowski, J.; Wagener, M.; Hemmer, M. C. A hierarchy of structure representation. Abstr. Pap. - Am. Chem. Soc. 2002, 223rd, CINF-002.
71. Brüstle, M.; Beck, B.; Schindler, T.; King, W.; Mitchell, T.; Clark, T. Descriptors, Physical Properties, and Drug-Likeness. J. Med. Chem. 2002, 45, 3345-3355.
72. E.g., Andres, C. J.; Macdonald, T. L.; Ocain, T. D.; Longhi, D. Conformationally defined analogs of prolylamides. Trans-Prolyl peptidomimetics. J. Org. Chem. 1993, 58, 6609-6613. Baginski, M.; Piela, L.; Skolnick, J. The ethylene group as a peptide bond mimicking unit: a theoretical conformational analysis. J. Comput. Chem. 1993, 14, 471-477. Shue, Y. K.; Tufano, M. D.; Carrera, G. M., Jr.; Kopecka, H.; Kuyper, S. L.; Holladay, M. W.; Lin, C. W.; Witte, D. G.; Miller, T. R. Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexa-peptide analogs. Bioorg. Med. Chem. 1993, 1, 161-171.
73. E.g., Andres, C. J.; Macdonald, T. L.; Ocain, T. D.; Longhi, D. Conformationally defined analogs of prolylamides. Trans-Prolyl peptidomimetics. J. Org. Chem. 1993, 58, 6609-6613. Baginski, M.; Piela, L.; Skolnick, J. The ethylene group as a peptide bond mimicking unit: a theoretical conformational analysis. J. Comput. Chem. 1993, 14, 471-477. Shue, Y. K.; Tufano, M. D.; Carrera, G. M., Jr.; Kopecka, H.; Kuyper, S. L.; Holladay, M. W.; Lin, C. W.; Witte, D. G.; Miller, T. R. Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexa-peptide analogs. Bioorg. Med. Chem. 1993, 1, 161-171.
74. Kagechika, H.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Differentiation inducers of human promyelocytic leukemia cells HL-60. Azobenzenecarboxylic acids and stilbenecarboxylic acids. Chem. Pharm. Bull. 1985, 33, 5597-5600. Kagechika, H.; Himi, T.; Namikawa, K.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Retinobenzoic acids. 3. Structure-activity relationships of retinoidal azobenzene-4-carboxylic acids and stilbene-4-carboxylic acids. J. Med. Chem. 1989, 32, 1098-1108.
75. Kagechika, H.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Differentiation inducers of human promyelocytic leukemia cells HL-60. Azobenzenecarboxylic acids and stilbenecarboxylic acids. Chem. Pharm. Bull. 1985, 33, 5597-5600. Kagechika, H.; Himi, T.; Namikawa, K.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Retinobenzoic acids. 3. Structure-activity relationships of retinoidal azobenzene-4-carboxylic acids and stilbene-4-carboxylic acids. J. Med. Chem. 1989, 32, 1098-1108.
76. Kagechika, H.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Differentiation inducers of human promyelocytic leukemia cells HL-60. Azobenzenecarboxylic acids and stilbenecarboxylic acids. Chem. Pharm. Bull. 1985, 33, 5597-5600. Kagechika, H.; Himi, T.; Namikawa, K.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Retinobenzoic acids. 3. Structure-activity relationships of retinoidal azobenzene-4-carboxylic acids and stilbene-4-carboxylic acids. J. Med. Chem. 1989, 32, 1098-1108.
77. Kagechika, H.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Differentiation inducers of human promyelocytic leukemia cells HL-60. Azobenzenecarboxylic acids and stilbenecarboxylic acids. Chem. Pharm. Bull. 1985, 33, 5597-5600. Kagechika, H.; Himi, T.; Namikawa, K.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Retinobenzoic acids. 3. Structure-activity relationships of retinoidal azobenzene-4-carboxylic acids and stilbene-4-carboxylic acids. J. Med. Chem. 1989, 32, 1098-1108.
78. Kagechika, H.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Differentiation inducers of human promyelocytic leukemia cells HL-60. Azobenzenecarboxylic acids and stilbenecarboxylic acids. Chem. Pharm. Bull. 1985, 33, 5597-5600. Kagechika, H.; Himi, T.; Namikawa, K.; Kawachi, E.; Hashimoto, Y.; Shudo, K. Retinobenzoic acids. 3. Structure-activity relationships of retinoidal azobenzene-4-carboxylic acids and stilbene-4-carboxylic acids. J. Med. Chem. 1989, 32, 1098-1108.
79. E.g., Adelstein, G. W. Antiarrhythmic agents. Synthesis and biological activity of some tetrazole and oxadiazole analogs of 4-dialkylamino-2,2-diarylbutyramides. J. Med. Chem. 1973, 16, 309-312. Harfenist, M.; Heuser, D. J.; Joyner, C. T.; Batchelor, J. F.; White, H. L. Selective Inhibitors of Monoamine Oxidase. 3. Structure-Activity Relationship of Tricyclics Bearing Imidazoline, Oxadiazole, or Tetrazole Groups. J. Med. Chem. 1996, 39, 1857-1863. Smith, P. W.; Whittington, A. R. Novel inhibitors of influenza sialidases related to zanamivir. Heterocyclic replacements of the glycerol sidechain. Bioorg. Med. Chem. Lett. 1997, 7, 2239-2242.
80. Fincham, C. I.; Higginbottom, M.; Hill, D. R.; Horwell, D. C.; O'Toole, J. C.; Ratcliffe, G. S.; Rees, D. C.; Roberts, E. Amide bond replacements incorporated into CCK-B selective "dipeptoids". J. Med. Chem. 1992, 35, 1472-1484.
81. a of the C-7 heterocycle. J. Med. Chem. 1991, 34, 1110-1116. Thompson, S. K.; Murthy, K. H. M.; Zhao, B.; Winborne, E.; Green, D. W.; Fisher, S. M.; DesJarlais, R. L.; Tomaszek, T. A., Jr.; Meek, T. D. Rational Design, Synthesis, and Crystallographic Analysis of a Hydroxyethylene-Based HIV-1 Protease Inhibitor Containing a Heterocyclic P1'-P2' Amide Bond Isostere. J. Med. Chem. 1994, 37, 3100-3107.
82. a of the C-7 heterocycle. J. Med. Chem. 1991, 34, 1110-1116. Thompson, S. K.; Murthy, K. H. M.; Zhao, B.; Winborne, E.; Green, D. W.; Fisher, S. M.; DesJarlais, R. L.; Tomaszek, T. A., Jr.; Meek, T. D. Rational Design, Synthesis, and Crystallographic Analysis of a Hydroxyethylene-Based HIV-1 Protease Inhibitor Containing a Heterocyclic P1′-P2′ Amide Bond Isostere. J. Med. Chem. 1994, 37, 3100-3107.
83. E.g., Pitt, B. Diversity of calcium antagonists. Clin. Therap. 1997, 19(Suppl. A), 3-17. Ferrari, R. Major differences among the three classes of calcium antagonists. Eur. Heart J. 1997, 18(Suppl. A), A56-A70. Triggle, D. J. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Clev. Clin. J. Med. 1992, 59, 617-627. Triggle, D. J. Sites, mechanisms of action, and differentiation of calcium channel antagonists. Am. J. Hypert. 1991, 4, 422S-429S.
84. E.g., Pitt, B. Diversity of calcium antagonists. Clin. Therap. 1997, 19(Suppl. A), 3-17. Ferrari, R. Major differences among the three classes of calcium antagonists. Eur. Heart J. 1997, 18(Suppl. A), A56-A70. Triggle, D. J. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Clev. Clin. J. Med. 1992, 59, 617-627. Triggle, D. J. Sites, mechanisms of action, and differentiation of calcium channel antagonists. Am. J. Hypert. 1991, 4, 422S-429S.
85. E.g., Pitt, B. Diversity of calcium antagonists. Clin. Therap. 1997, 19(Suppl. A), 3-17. Ferrari, R. Major differences among the three classes of calcium antagonists. Eur. Heart J. 1997, 18(Suppl. A), A56-A70. Triggle, D. J. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Clev. Clin. J. Med. 1992, 59, 617-627. Triggle, D. J. Sites, mechanisms of action, and differentiation of calcium channel antagonists. Am. J. Hypert. 1991, 4, 422S-429S.
86. E.g., Pitt, B. Diversity of calcium antagonists. Clin. Therap. 1997, 19(Suppl. A), 3-17. Ferrari, R. Major differences among the three classes of calcium antagonists. Eur. Heart J. 1997, 18(Suppl. A), A56-A70. Triggle, D. J. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Clev. Clin. J. Med. 1992, 59, 617-627. Triggle, D. J. Sites, mechanisms of action, and differentiation of calcium channel antagonists. Am. J. Hypert. 1991, 4, 422S-429S.
87. Sadowski, J.; Wagener, M.; Gasteiger, J. Assessing similarity and diversity of combinatorial libraries by spatial autocorrelation functions and neural networks. Angew. Chem., Int. Ed. Engl. 1996, 34, 2674-2677.
88. Schwarz, M. K.; Sauer, W. H. B. Manuscript in preparation.